BIOMAT Database Logo BIOMAT Database Logo

Minimizing ciclosporin in renal transplant recipients on daclizumab, mycophenolate and steroids. 2007

Suphamai Bunnapradist, and Gabriel M Danovitch
David Geffen School of Medicine, Department of Medicine, Division of Nephrology, Kidney and Pancreas Transplant Research Office, Los Angeles, CA 90095-7306, USA. bunnapradist@mednet.ucla.edu

UI MeSH Term Description Entries

Related Publications

Suphamai Bunnapradist, and Gabriel M Danovitch
Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients.
August 2002, Transplantation proceedings,
Suphamai Bunnapradist, and Gabriel M Danovitch
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients.
August 2002, Transplantation proceedings,
Suphamai Bunnapradist, and Gabriel M Danovitch
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.
January 2001, Transplantation proceedings,
Suphamai Bunnapradist, and Gabriel M Danovitch
Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
April 2002, Transplantation,
Suphamai Bunnapradist, and Gabriel M Danovitch
A prospective randomized open study in liver transplant recipients: daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids.
November 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Suphamai Bunnapradist, and Gabriel M Danovitch
The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients.
August 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Suphamai Bunnapradist, and Gabriel M Danovitch
Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients.
August 2002, Transplantation proceedings,
Suphamai Bunnapradist, and Gabriel M Danovitch
Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation.
December 2003, Clinical transplantation,
Suphamai Bunnapradist, and Gabriel M Danovitch
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids.
October 2000, Journal of the American Society of Nephrology : JASN,
Suphamai Bunnapradist, and Gabriel M Danovitch
Cytomegaloviral infections in renal transplant recipients treated with daclizumab.
March 2000, Transplantation,
Copied contents to your clipboard!